Bicycle Therapeutics (BCYC) Current Leases (2019 - 2025)
Historic Current Leases for Bicycle Therapeutics (BCYC) over the last 7 years, with Q2 2025 value amounting to $5.2 million.
- Bicycle Therapeutics' Current Leases rose 264.81% to $5.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $5.2 million, marking a year-over-year increase of 264.81%. This contributed to the annual value of $5.3 million for FY2024, which is 926.99% up from last year.
- Latest data reveals that Bicycle Therapeutics reported Current Leases of $5.2 million as of Q2 2025, which was up 264.81% from $5.5 million recorded in Q1 2025.
- Bicycle Therapeutics' 5-year Current Leases high stood at $5.5 million for Q1 2025, and its period low was $708000.0 during Q1 2021.
- Over the past 5 years, Bicycle Therapeutics' median Current Leases value was $4.7 million (recorded in 2023), while the average stood at $3.7 million.
- Per our database at Business Quant, Bicycle Therapeutics' Current Leases skyrocketed by 32316.38% in 2022 and then skyrocketed by 264.81% in 2025.
- Bicycle Therapeutics' Current Leases (Quarter) stood at $2.4 million in 2021, then skyrocketed by 31.14% to $3.1 million in 2022, then soared by 56.03% to $4.9 million in 2023, then increased by 9.27% to $5.3 million in 2024, then decreased by 1.78% to $5.2 million in 2025.
- Its Current Leases was $5.2 million in Q2 2025, compared to $5.5 million in Q1 2025 and $5.3 million in Q4 2024.